Search

Your search keyword '"Naohiko Fujii"' showing total 111 results

Search Constraints

Start Over You searched for: Author "Naohiko Fujii" Remove constraint Author: "Naohiko Fujii"
111 results on '"Naohiko Fujii"'

Search Results

1. Risedronate prevents exercise-induced hypercalcemia but not nausea or vomit in humans: a double blind randomized controlled trial

2. Changes in 3-month mineral and bone disorder patterns were associated with all-cause mortality in prevalent hemodialysis patients with secondary hyperparathyroidism

3. Clinical practice guideline for renal rehabilitation: systematic reviews and recommendations of exercise therapies in patients with kidney diseases

4. Hematuria as a risk factor for progression of chronic kidney disease and death: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study

5. Red cell distribution width and renal outcome in patients with non-dialysis-dependent chronic kidney disease.

6. Magnesium modifies the cardiovascular mortality risk associated with hyperphosphatemia in patients undergoing hemodialysis: a cohort study.

7. Lenalidomide and Dexamethasone for a Patient of POEMS Syndrome Presenting with Massive Ascites

8. Excess risk of cardiovascular events in patients in the United States vs. Japan with chronic kidney disease is mediated mainly by left ventricular structure and function

9. Assessment of Tumor Markers in Renal Transplant Recipients.

10. Association between serum iron markers, iron supplementation, and cardiovascular morbidity in pre-dialysis chronic kidney disease

11. Supplementary Table 1 from Orally Active Vitamin D for Potential Chemoprevention of Posttransplant Malignancy

12. Data from Orally Active Vitamin D for Potential Chemoprevention of Posttransplant Malignancy

13. Biopsy-proven CKD etiology and outcomes: the Chronic Kidney Disease Japan Cohort (CKD-JAC) study

14. Parathyroidectomy vs Cinacalcet Among Patients Undergoing Hemodialysis

15. A Comparative Study of Serum Phosphate and Related Parameters in Chronic Kidney Disease between the USA and Japan

16. Risedronate prevents exercise-induced hypercalcemia but not nausea or vomit in humans: a double-blind randomized controlled trial

17. Cardiovascular disease history and β-blocker prescription patterns among Japanese and American patients with CKD: a cross-sectional study of the CRIC and CKD-JAC studies

18. Evinacumab for Homozygous Familial Hypercholesterolemia

19. Serum phosphate levels modify the impact of parathyroid hormone levels on renal outcomes in kidney transplant recipients

20. P0829THE ASSOCIATION BETWEEN URINARY NGAL AND EGFR SLOPE IN PATIENTS WITH CKD

21. High Titer of Acquired Factor V Inhibitor Presenting with a Pseudo-deficiency of Multiple Coagulation Factors

22. Changes in 3-month mineral and bone disorder patterns were associated with all-cause mortality in prevalent hemodialysis patients with secondary hyperparathyroidism

23. A collaborative, individual-level analysis compared longitudinal outcomes across the International Network of Chronic Kidney Disease (iNETCKD) cohorts

25. New selectivity index calculated using protein fraction as a substitute for the conventional selectivity index

26. Relationship of eGFR and Albuminuria to concurrent laboratory abnormalities: An individual participant data meta-analysis in a global consortium

27. [Bone and Mineral Metabolism in Hemodialysis Patients. Fragility Fractures in Hemodialysis Patients.]

28. Variations in 24-Hour BP Profiles in Cohorts of Patients with Kidney Disease around the World: The I-DARE Study

29. Peritoneal Dialysis Registry With 2012 Survey Report

30. Red cell distribution width and renal outcome in patients with non-dialysis-dependent chronic kidney disease

31. An Overview of Regular Dialysis Treatment in Japan (as of 31 December 2012)

32. Dietary L-Lysine Prevents Arterial Calcification in Adenine-Induced Uremic Rats

33. Vitamin D Deficiency Predicts Decline in Kidney Allograft Function: A Prospective Cohort Study

34. Overview of Regular Dialysis Treatment in Japan (as of 31 December 2011)

35. Fibroblast growth factor 23 and 25-hydroxyvitamin D levels are associated with estimated glomerular filtration rate decline

36. Multidetector-row computed tomography is useful to evaluate the therapeutic effects of bisphosphonates in glucocorticoid-induced osteoporosis

37. Clinical Practice Guideline for the Management of Chronic Kidney Disease-Mineral and Bone Disorder

38. Serum Phosphate and Calcium Should Be Primarily and Consistently Controlled in Prevalent Hemodialysis Patients

39. Retention of fetuin-A in renal tubular lumen protects the kidney from nephrocalcinosis in rats

40. Clinical features of CKD-MBD in Japan: cohort studies and registry

41. Maxacalcitol ameliorates tubulointerstitial fibrosis in obstructed kidneys by recruiting PPM1A/VDR complex to pSmad3

42. An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2010)

43. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation

44. Intact fibroblast growth factor 23 levels predict incident cardiovascular event before but not after the start of dialysis

45. Clinical Nephrology - Epidemiology I

46. Overview of Regular Dialysis Treatment in Japan (as of 31 December 2009)

48. Guideline-Practice Gap in the Management of Predialysis Chronic Kidney Disease Mineral Bone Disorder in Japan

49. FO027THE EFFECT OF EXERCISE INTERVENTION ON EXERCISE TOLERANCE IN PATIENTS WITH NON-DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW

Catalog

Books, media, physical & digital resources